Scientists around the world are resuming trials of the controversial drug hydroxychloroquine for possible use against COVID-19, after the retraction of a heavily criticised study into its effects and side-effects. Now the paper has been retracted, and the WHO trials are back on after several of the paper's authors said they were not able to verify the contents of a database at the heart of the study.

Lancet cities lack of data authenticity: Study that paused HCQ trails now retracted

lancet-study-on-hcq

Lancet Study On Hcq, News on Lancet Study On Hcq, stories on Lancet Study On Hcq, articles on Lancet Study On Hcq, Lancet Study On Hcq stories at Wion, Lancet Study On Hcq news, Lancet Study On Hcq latest news

lancet study-on-hcq

Lancet cities lack of data authenticity: Study that paused HCQ trails now retracted